| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.686 | 0.003 | 0.686 | Peroxidase inhibitor | |||
| 0.617 | 0.003 | 0.617 | Cystathionine beta-synthase inhibitor | 0.564 0.003 CID_154699729 | ||
| 0.611 | 0.006 | 0.611 | GABA C receptor rho-3 antagonist | |||
| 0.593 | 0.02 | 0.593 | Aldehyde oxidase inhibitor | |||
| 0.542 | 0.021 | 0.65 | 5 Hydroxytryptamine release inhibitor | 0.65 0.006 CID_154699729 | CID_154699729 | |
| 0.514 | 0.005 | 0.578 | NOS3 expression enhancer | 0.578 0.004 CID_154699729 | CID_154699729 | |
| 0.529 | 0.05 | 0.563 | Caspase 9 stimulant | 0.563 0.042 CID_154699729 | CID_154699729 | |
| 0.491 | 0.022 | 0.491 | 12-Lipoxygenase inhibitor | |||
| 0.465 | 0.006 | 0.465 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.428 | 0.004 | 0.428 | M18 aspartyl aminopeptidase inhibitor | 0.103 0.089 CID_154699729 | ||
| 0.423 | 0.004 | 0.423 | Estrogen receptor beta antagonist | |||
| 0.463 | 0.05 | 0.463 | 15-Lipoxygenase inhibitor | |||
| 0.456 | 0.047 | 0.592 | Histamine release inhibitor | 0.592 0.011 CID_154699729 | CID_154699729 | |
| 0.412 | 0.005 | 0.412 | Interleukin 4 antagonist | 0.237 0.015 CID_154699729 | ||
| 0.436 | 0.031 | 0.436 | Aryl hydrocarbon receptor agonist | 0.149 0.136 CID_154699729 | ||
| 0.39 | 0.005 | 0.39 | Estrogen antagonist | 0.103 0.091 CID_154699729 | ||
| 0.424 | 0.041 | 0.424 | 5 Hydroxytryptamine release stimulant | 0.294 0.072 CID_154699729 | ||
| 0.363 | 0.005 | 0.363 | Succinate dehydrogenase inhibitor | 0.208 0.043 CID_154699729 | ||
| 0.369 | 0.018 | 0.369 | Dual specificity phosphatase 3 inhibitor | |||
| 0.342 | 0.009 | 0.342 | Heat shock protein 90 alpha antagonist | |||
| 0.43 | 0.1 | 0.651 | Apoptosis agonist | 0.651 0.039 CID_154699729 | CID_154699729 | |
| 0.343 | 0.014 | 0.684 | Amylase inhibitor | 0.684 0.003 CID_154699729 | CID_154699729 | |
| 0.333 | 0.009 | 0.477 | UDP-glucose 4-epimerase inhibitor | 0.477 0.003 CID_154699729 | CID_154699729 | |
| 0.36 | 0.037 | 0.644 | Free radical scavenger | 0.644 0.007 CID_154699729 | CID_154699729 | |
| 0.353 | 0.036 | 0.353 | Superoxide dismutase inhibitor | |||
| 0.357 | 0.045 | 0.688 | Antioxidant | 0.688 0.006 CID_154699729 | CID_154699729 | |
| 0.338 | 0.025 | 0.338 | RNA-directed DNA polymerase inhibitor | 0.29 0.034 CID_154699729 | ||
| 0.318 | 0.008 | 0.318 | Heat shock protein 90 antagonist | |||
| 0.364 | 0.055 | 0.408 | Caspase 3 stimulant | 0.408 0.042 CID_154699729 | CID_154699729 | |
| 0.313 | 0.009 | 0.336 | Nitric-oxide synthase stimulant | 0.336 0.005 CID_154699729 | CID_154699729 | |
| 0.376 | 0.074 | 0.376 | Prostaglandin dehydrogenase inhibitor | |||
| 0.326 | 0.024 | 0.326 | Dual specificity phosphatase inhibitor | |||
| 0.385 | 0.084 | 0.685 | Antibacterial | 0.685 0.01 CID_154699729 | CID_154699729 | |
| 0.353 | 0.054 | 0.582 | Vasodilator, coronary | 0.582 0.009 CID_154699729 | CID_154699729 | |
| 0.317 | 0.026 | 0.317 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.289 | 0.006 | 0.306 | Mannose-6-phosphate isomerase inhibitor | 0.306 0.005 CID_154699729 | CID_154699729 | |
| 0.287 | 0.004 | 0.287 | Creatine kinase inhibitor | 0.088 0.075 CID_154699729 | ||
| 0.354 | 0.076 | 0.658 | Transcription factor NF kappa B inhibitor | 0.658 0.025 CID_154699729 | CID_154699729 | |
| 0.391 | 0.119 | 0.706 | Alpha-glucosidase inhibitor | 0.706 0.033 CID_154699729 | CID_154699729 | |
| 0.337 | 0.07 | 0.617 | Cholesterol antagonist | 0.617 0.016 CID_154699729 | CID_154699729 | |
| 0.285 | 0.018 | 0.505 | Alpha-N-acetylglucosaminidase inhibitor | 0.505 0.005 CID_154699729 | CID_154699729 | |
| 0.321 | 0.061 | 0.321 | Lipoxygenase inhibitor | |||
| 0.287 | 0.028 | 0.287 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.198 0.074 CID_154699729 | ||
| 0.344 | 0.09 | 0.545 | Immunosuppressant | 0.545 0.022 CID_154699729 | CID_154699729 | |
| 0.274 | 0.024 | 0.274 | MAO inhibitor | |||
| 0.254 | 0.009 | 0.254 | Histidine decarboxylase inhibitor | |||
| 0.25 | 0.008 | 0.25 | Dopamine D1 antagonist | |||
| 0.238 | 0.009 | 0.238 | Potassium channel (Ca-activated) activator | |||
| 0.229 | 0.005 | 0.229 | Dopamine D5 antagonist | |||
| 0.276 | 0.053 | 0.419 | DNA synthesis inhibitor | 0.419 0.019 CID_154699729 | CID_154699729 | |
| 0.236 | 0.015 | 0.236 | GABA C receptor rho-2 antagonist | |||
| 0.225 | 0.004 | 0.225 | DOPA decarboxylase inhibitor | |||
| 0.293 | 0.082 | 0.293 | Streptokinase A inhibitor | |||
| 0.255 | 0.048 | 0.255 | Anesthetic general | 0.253 0.049 CID_154699729 | ||
| 0.214 | 0.009 | 0.431 | NADH dehydrogenase inhibitor | 0.431 0.004 CID_154699729 | CID_154699729 | |
| 0.223 | 0.02 | 0.223 | MAO B inhibitor | |||
| 0.214 | 0.011 | 0.223 | Uric acid excretion stimulant | 0.223 0.01 CID_154699729 | CID_154699729 | |
| 0.22 | 0.017 | 0.22 | GABA C receptor agonist | |||
| 0.231 | 0.029 | 0.231 | Phospholipase C inhibitor | 0.224 0.032 CID_154699729 | ||
| 0.209 | 0.008 | 0.209 | Estrogen receptor alpha antagonist | |||
| 0.207 | 0.006 | 0.207 | Potassium channel large-conductance Ca-activated activator | 0.062 0.057 CID_154699729 | ||
| 0.296 | 0.096 | 0.296 | Calcium channel activator | |||
| 0.226 | 0.025 | 0.259 | Alkaline phosphatase inhibitor | 0.259 0.018 CID_154699729 | CID_154699729 | |
| 0.226 | 0.027 | 0.226 | NADPH oxidase inhibitor | 0.225 0.027 CID_154699729 | ||
| 0.218 | 0.018 | 0.218 | Arachidonic acid antagonist | 0.163 0.073 CID_154699729 | ||
| 0.206 | 0.007 | 0.206 | Macrophage migration inhibitory factor inhibitor | |||
| 0.208 | 0.011 | 0.208 | Interleukin 8 antagonist | 0.119 0.062 CID_154699729 | ||
| 0.262 | 0.066 | 0.262 | Dyrk kinase inhibitor | |||
| 0.22 | 0.024 | 0.386 | ATPase inhibitor | 0.386 0.004 CID_154699729 | CID_154699729 | |
| 0.206 | 0.01 | 0.206 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.204 | 0.012 | 0.204 | GABA C receptor antagonist | |||
| 0.272 | 0.082 | 0.433 | Spasmolytic | 0.433 0.034 CID_154699729 | CID_154699729 | |
| 0.231 | 0.04 | 0.231 | Amyloid beta precursor protein antagonist | |||
| 0.221 | 0.034 | 0.418 | Melanin inhibitor | 0.418 0.011 CID_154699729 | CID_154699729 | |
| 0.213 | 0.027 | 0.213 | MAO A inhibitor | |||
| 0.254 | 0.069 | 0.381 | Antiamyloidogenic | 0.381 0.032 CID_154699729 | CID_154699729 | |
| 0.231 | 0.05 | 0.244 | Neurotrophic factor enhancer | 0.244 0.042 CID_154699729 | CID_154699729 | |
| 0.195 | 0.019 | 0.195 | Carbonic anhydrase XV inhibitor | |||
| 0.238 | 0.066 | 0.238 | Interleukin antagonist | |||
| 0.183 | 0.012 | 0.183 | Urease inhibitor | |||
| 0.254 | 0.084 | 0.254 | Transcription factor STAT inhibitor | |||
| 0.26 | 0.092 | 0.298 | Hypoxia-inducible factor 1 alpha inhibitor | 0.298 0.067 CID_154699729 | CID_154699729 | |
| 0.171 | 0.005 | 0.171 | Estrogen receptor beta agonist | 0.026 0.025 CID_154699729 | ||
| 0.209 | 0.043 | 0.209 | Protein-tyrosine phosphatase inhibitor | 0.173 0.06 CID_154699729 | ||
| 0.245 | 0.08 | 0.245 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.254 | 0.092 | 0.254 | Insulysin inhibitor | |||
| 0.164 | 0.004 | 0.164 | Aryl hydrocarbon receptor antagonist | |||
| 0.203 | 0.043 | 0.432 | Diuretic | 0.432 0.011 CID_154699729 | CID_154699729 | |
| 0.171 | 0.012 | 0.171 | Ca2+-transporting ATPase inhibitor | 0.165 0.017 CID_154699729 | ||
| 0.192 | 0.033 | 0.347 | Cell wall synthesis inhibitor | 0.347 0.008 CID_154699729 | CID_154699729 | |
| 0.162 | 0.004 | 0.162 | D-Ala-D-Ala ligase inhibitor | |||
| 0.226 | 0.069 | 0.226 | Pyruvate kinase inhibitor | |||
| 0.33 | 0.174 | 0.33 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.172 | 0.021 | 0.257 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.257 0.009 CID_154699729 | CID_154699729 | |
| 0.161 | 0.01 | 0.161 | Estrogen agonist | 0.063 0.029 CID_154699729 | ||
| 0.168 | 0.019 | 0.182 | Heat shock protein 70 antagonist | 0.182 0.011 CID_154699729 | CID_154699729 | |
| 0.163 | 0.017 | 0.163 | Protein kinase C zeta inhibitor | |||
| 0.15 | 0.005 | 0.15 | Heat shock protein 90 beta antagonist | |||
| 0.163 | 0.02 | 0.52 | Beta glucuronidase inhibitor | 0.52 0.003 CID_154699729 | CID_154699729 | |
| 0.15 | 0.007 | 0.15 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.141 0.008 CID_154699729 | ||
| 0.16 | 0.018 | 0.16 | GABA C receptor rho-1 antagonist | |||
| 0.203 | 0.063 | 0.565 | Hepatoprotectant | 0.565 0.005 CID_154699729 | CID_154699729 | |
| 0.171 | 0.032 | 0.171 | Protein kinase (CK2) alpha inhibitor | |||
| 0.157 | 0.018 | 0.157 | Transcription factor STAT6 inhibitor | |||
| 0.2 | 0.062 | 0.2 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.147 | 0.01 | 0.166 | Glutamate release inhibitor | 0.166 0.007 CID_154699729 | CID_154699729 | |
| 0.154 | 0.018 | 0.154 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.161 | 0.025 | 0.161 | Carbonic anhydrase III inhibitor | 0.108 0.054 CID_154699729 | ||
| 0.148 | 0.014 | 0.148 | Cyclin B3 inhibitor | |||
| 0.162 | 0.029 | 0.162 | 5 Hydroxytryptamine 3A agonist | |||
| 0.154 | 0.022 | 0.27 | Topoisomerase II alpha inhibitor | 0.27 0.009 CID_154699729 | CID_154699729 | |
| 0.166 | 0.036 | 0.433 | Cyclooxygenase 3 inhibitor | 0.433 0.004 CID_154699729 | CID_154699729 | |
| 0.14 | 0.012 | 0.167 | Aldose reductase inhibitor | 0.167 0.009 CID_154699729 | CID_154699729 | |
| 0.167 | 0.038 | 0.167 | Adenylate cyclase stimulant | |||
| 0.179 | 0.051 | 0.341 | Interferon gamma antagonist | 0.341 0.015 CID_154699729 | CID_154699729 | |
| 0.149 | 0.021 | 0.149 | Carbonic anhydrase VI inhibitor | 0.087 0.05 CID_154699729 | ||
| 0.157 | 0.035 | 0.157 | Ferrochelatase inhibitor | |||
| 0.209 | 0.087 | 0.209 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.173 | 0.055 | 0.173 | Cyclooxygenase inhibitor | 0.129 0.088 CID_154699729 | ||
| 0.15 | 0.033 | 0.15 | Protein kinase (CK2) inhibitor | |||
| 0.124 | 0.008 | 0.124 | Protease activated receptor antagonist | |||
| 0.119 | 0.005 | 0.119 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.187 | 0.073 | 0.497 | Nitric oxide antagonist | 0.497 0.016 CID_154699729 | CID_154699729 | |
| 0.155 | 0.042 | 0.155 | Cholesterol synthesis inhibitor | 0.116 0.069 CID_154699729 | ||
| 0.137 | 0.025 | 0.137 | Electrolyte absorption antagonist | |||
| 0.22 | 0.109 | 0.555 | Immunostimulant | 0.555 0.022 CID_154699729 | CID_154699729 | |
| 0.207 | 0.096 | 0.207 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.212 | 0.102 | 0.731 | Hypoglycemic | 0.731 0.005 CID_154699729 | CID_154699729 | |
| 0.135 | 0.025 | 0.19 | Carbonic anhydrase XIII inhibitor | 0.19 0.015 CID_154699729 | CID_154699729 | |
| 0.176 | 0.068 | 0.176 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.157 | 0.049 | 0.157 | Cyclooxygenase 2 inhibitor | 0.115 0.086 CID_154699729 | ||
| 0.133 | 0.026 | 0.299 | Triose-phosphate isomerase inhibitor | 0.299 0.005 CID_154699729 | CID_154699729 | |
| 0.153 | 0.046 | 0.164 | Aldehyde dehydrogenase inhibitor | 0.164 0.04 CID_154699729 | CID_154699729 | |
| 0.128 | 0.023 | 0.128 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.14 | 0.035 | 0.451 | AMP-activated protein kinase stimulant | 0.451 0.004 CID_154699729 | CID_154699729 | |
| 0.11 | 0.007 | 0.11 | Estrogen receptor alpha agonist | |||
| 0.143 | 0.041 | 0.143 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.174 | 0.071 | 0.174 | Mcl-1 antagonist | |||
| 0.145 | 0.043 | 0.294 | Topoisomerase I inhibitor | 0.294 0.011 CID_154699729 | CID_154699729 | |
| 0.162 | 0.06 | 0.31 | Protein kinase stimulant | 0.31 0.015 CID_154699729 | CID_154699729 | |
| 0.161 | 0.059 | 0.161 | CF transmembrane conductance regulator agonist | |||
| 0.122 | 0.021 | 0.122 | Carbonic anhydrase V inhibitor | |||
| 0.147 | 0.047 | 0.147 | Adenylate cyclase inhibitor | |||
| 0.206 | 0.109 | 0.206 | Neuropeptide Y2 antagonist | |||
| 0.1 | 0.003 | 0.1 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.039 0.036 CID_154699729 | ||
| 0.115 | 0.019 | 0.115 | Aromatase inhibitor | |||
| 0.13 | 0.034 | 0.192 | Toll-Like receptor 4 antagonist | 0.192 0.007 CID_154699729 | CID_154699729 | |
| 0.099 | 0.003 | 0.099 | ATP citrate lysase inhibitor | |||
| 0.107 | 0.012 | 0.107 | GABA B receptor agonist | |||
| 0.099 | 0.004 | 0.099 | Dopamine D5 agonist | |||
| 0.103 | 0.01 | 0.103 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.185 | 0.092 | 0.185 | MAP kinase kinase 2 inhibitor | |||
| 0.181 | 0.088 | 0.181 | Amyloid beta aggregation inhibitor | 0.136 0.119 CID_154699729 | ||
| 0.164 | 0.071 | 0.164 | Neurotensin receptor agonist | |||
| 0.102 | 0.01 | 0.102 | NMDA receptor subunit 3B antagonist | |||
| 0.114 | 0.022 | 0.114 | Dopamine agonist | |||
| 0.117 | 0.026 | 0.117 | Interleukin 5 antagonist | 0.113 0.029 CID_154699729 | ||
| 0.148 | 0.057 | 0.148 | Cyclooxygenase 1 inhibitor | 0.124 0.076 CID_154699729 | ||
| 0.114 | 0.023 | 0.114 | Glutamate decarboxylase inhibitor | |||
| 0.105 | 0.015 | 0.105 | Purinergic P2X1 antagonist | 0.054 0.053 CID_154699729 | ||
| 0.1 | 0.011 | 0.1 | Glutamate (mGluR7) antagonist | |||
| 0.115 | 0.026 | 0.219 | Phosphofructokinase-1 inhibitor | 0.219 0.009 CID_154699729 | CID_154699729 | |
| 0.139 | 0.051 | 0.139 | Vanilloid 1 agonist | 0.119 0.091 CID_154699729 | ||
| 0.127 | 0.038 | 0.127 | Adenylate kinase inhibitor | 0.107 0.058 CID_154699729 | ||
| 0.124 | 0.036 | 0.124 | Anabolic | |||
| 0.116 | 0.03 | 0.116 | Porphobilinogen synthase inhibitor | |||
| 0.173 | 0.087 | 0.189 | P-glycoprotein inhibitor | 0.189 0.072 CID_154699729 | CID_154699729 | |
| 0.097 | 0.011 | 0.097 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.103 | 0.017 | 0.103 | Alcohol oxidase inhibitor | |||
| 0.14 | 0.055 | 0.14 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.117 | 0.033 | 0.117 | Dopamine antagonist | |||
| 0.17 | 0.086 | 0.369 | DNA methyltransferase I inhibitor | 0.369 0.012 CID_154699729 | CID_154699729 | |
| 0.106 | 0.023 | 0.126 | GABA aminotransferase inhibitor | 0.126 0.014 CID_154699729 | CID_154699729 | |
| 0.087 | 0.004 | 0.087 | Kynurenine 3 monooxygenase inhibitor | 0.052 0.006 CID_154699729 | ||
| 0.228 | 0.146 | 0.243 | Vasodilator, peripheral | 0.243 0.132 CID_154699729 | CID_154699729 | |
| 0.095 | 0.013 | 0.095 | Glutamate (mGluR6) antagonist | |||
| 0.138 | 0.056 | 0.329 | Topoisomerase II inhibitor | 0.329 0.015 CID_154699729 | CID_154699729 | |
| 0.087 | 0.005 | 0.087 | Pregnane X receptor antagonist | |||
| 0.115 | 0.034 | 0.115 | ABCA1 expression enhancer | |||
| 0.1 | 0.02 | 0.1 | Carbamoyl phosphate synthetase inhibitor | 0.058 0.045 CID_154699729 | ||
| 0.105 | 0.025 | 0.105 | CDC25A inhibitor | |||
| 0.115 | 0.036 | 0.115 | Androgen antagonist | |||
| 0.107 | 0.028 | 0.107 | Myeloperoxidase inhibitor | |||
| 0.096 | 0.019 | 0.096 | NMDA receptor glycine site agonist | |||
| 0.1 | 0.024 | 0.1 | Estrogen-related receptor beta agonist | |||
| 0.118 | 0.043 | 0.118 | Sphingomyelinase inhibitor | 0.097 0.063 CID_154699729 | ||
| 0.1 | 0.025 | 0.1 | HIV-1 integrase inhibitor | |||
| 0.141 | 0.067 | 0.141 | Bone formation stimulant | 0.113 0.092 CID_154699729 | ||
| 0.103 | 0.03 | 0.103 | mTOR complex 2 inhibitor | |||
| 0.119 | 0.048 | 0.246 | Xanthine oxidase inhibitor | 0.246 0.013 CID_154699729 | CID_154699729 | |
| 0.082 | 0.013 | 0.082 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.096 | 0.029 | 0.096 | Lipase inhibitor | |||
| 0.14 | 0.073 | 0.14 | Pregnane X receptor agonist | |||
| 0.148 | 0.081 | 0.276 | Hexokinase inhibitor | 0.276 0.013 CID_154699729 | CID_154699729 | |
| 0.127 | 0.06 | 0.269 | DNA repair enzyme inhibitor | 0.269 0.005 CID_154699729 | CID_154699729 | |
| 0.085 | 0.019 | 0.085 | Exportin-1 inhibitor | |||
| 0.122 | 0.056 | 0.122 | TRPA1 agonist | |||
| 0.094 | 0.029 | 0.094 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.109 | 0.044 | 0.109 | Glutamate (mGluR7) agonist | |||
| 0.189 | 0.125 | 0.249 | DNA damaging | 0.249 0.081 CID_154699729 | CID_154699729 | |
| 0.101 | 0.038 | 0.14 | ATPase (Vacuolar H+) inhibitor | 0.14 0.01 CID_154699729 | CID_154699729 | |
| 0.09 | 0.028 | 0.09 | Glycine receptor agonist | 0.079 0.04 CID_154699729 | ||
| 0.091 | 0.03 | 0.091 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.124 | 0.063 | 0.153 | Beta amyloid protein antagonist | 0.153 0.038 CID_154699729 | CID_154699729 | |
| 0.099 | 0.038 | 0.099 | Adrenaline agonist | |||
| 0.092 | 0.031 | 0.092 | Phosphodiesterase 5A inhibitor | |||
| 0.071 | 0.011 | 0.071 | Potassium channel (Inward rectifier) activator | |||
| 0.082 | 0.023 | 0.082 | Xanthine dehydrogenase inhibitor | |||
| 0.072 | 0.014 | 0.072 | NMDA receptor subunit 3A antagonist | |||
| 0.107 | 0.048 | 0.107 | MAP kinase kinase 1 inhibitor | |||
| 0.065 | 0.007 | 0.065 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.091 | 0.032 | 0.091 | Phosphodiesterase V inhibitor | |||
| 0.139 | 0.081 | 0.139 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.163 | 0.106 | 0.376 | DNA methylase inhibitor | 0.376 0.013 CID_154699729 | CID_154699729 | |
| 0.092 | 0.035 | 0.092 | Glutamate dehydrogenase inhibitor | 0.07 0.057 CID_154699729 | ||
| 0.07 | 0.013 | 0.105 | Glucose-6-phosphate isomerase inhibitor | 0.105 0.004 CID_154699729 | CID_154699729 | |
| 0.068 | 0.011 | 0.068 | Potassium channel (ATP-sensitive) activator | |||
| 0.074 | 0.018 | 0.074 | 5 Hydroxytryptamine 2 agonist | |||
| 0.066 | 0.01 | 0.066 | Phosphoglycerate kinase inhibitor | |||
| 0.166 | 0.112 | 0.178 | Insulin sensitizer | 0.178 0.098 CID_154699729 | CID_154699729 | |
| 0.122 | 0.069 | 0.122 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.064 | 0.012 | 0.064 | Purinergic P2X4 antagonist | |||
| 0.11 | 0.058 | 0.11 | Aminopeptidase B inhibitor | |||
| 0.057 | 0.005 | 0.057 | CF transmembrane conductance regulator antagonist | |||
| 0.084 | 0.032 | 0.084 | HIV-1 integrase (3'-Processing) inhibitor | 0.058 0.049 CID_154699729 | ||
| 0.113 | 0.061 | 0.113 | EphA2 antagonist | |||
| 0.08 | 0.029 | 0.08 | NMDA receptor agonist | |||
| 0.131 | 0.083 | 0.323 | Lipid peroxidase inhibitor | 0.323 0.016 CID_154699729 | CID_154699729 | |
| 0.054 | 0.005 | 0.145 | Sodium/glucose cotransporter 2 inhibitor | 0.145 0.001 CID_154699729 | CID_154699729 | |
| 0.114 | 0.066 | 0.292 | Monophenol monooxygenase inhibitor | 0.292 0.019 CID_154699729 | CID_154699729 | |
| 0.075 | 0.027 | 0.075 | Androgen agonist | |||
| 0.097 | 0.049 | 0.097 | Aminoacyl-tRNA synthetase inhibitor | 0.083 0.07 CID_154699729 | ||
| 0.089 | 0.042 | 0.119 | Na+ K+ transporting ATPase inhibitor | 0.119 0.017 CID_154699729 | CID_154699729 | |
| 0.181 | 0.133 | 0.181 | Calpain inhibitor | |||
| 0.109 | 0.063 | 0.149 | Multidrug resistance-associated protein 1 inhibitor | 0.149 0.025 CID_154699729 | CID_154699729 | |
| 0.064 | 0.018 | 0.064 | CD45 antagonist | |||
| 0.155 | 0.109 | 0.402 | Non-steroidal antiinflammatory agent | 0.402 0.013 CID_154699729 | CID_154699729 | |
| 0.174 | 0.128 | 0.38 | Vasodilator | 0.38 0.027 CID_154699729 | CID_154699729 | |
| 0.078 | 0.032 | 0.078 | HIV-1 integrase (Strand Transfer) inhibitor | 0.055 0.046 CID_154699729 | ||
| 0.079 | 0.035 | 0.079 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.083 | 0.038 | 0.083 | Dopamine D2 antagonist | |||
| 0.07 | 0.026 | 0.08 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.08 0.02 CID_154699729 | CID_154699729 | |
| 0.058 | 0.014 | 0.058 | GABA B receptor antagonist | |||
| 0.059 | 0.016 | 0.059 | Dopamine beta hydroxylase inhibitor | |||
| 0.12 | 0.077 | 0.12 | Toll-Like receptor 2 antagonist | |||
| 0.064 | 0.022 | 0.064 | Leukotriene C antagonist | |||
| 0.127 | 0.085 | 0.159 | CC chemokine 6 receptor antagonist | 0.159 0.013 CID_154699729 | CID_154699729 | |
| 0.047 | 0.006 | 0.047 | Estrogen-related receptor beta antagonist | |||
| 0.095 | 0.054 | 0.095 | Potassium channel activator | |||
| 0.075 | 0.034 | 0.075 | Dopamine D4 antagonist | |||
| 0.091 | 0.05 | 0.091 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.067 | 0.028 | 0.067 | Fatty acid synthase inhibitor | |||
| 0.081 | 0.042 | 0.081 | Adenosine A3 receptor antagonist | |||
| 0.096 | 0.057 | 0.098 | Alcohol dehydrogenase inhibitor | 0.098 0.054 CID_154699729 | CID_154699729 | |
| 0.111 | 0.072 | 0.174 | Microtubule formation inhibitor | 0.174 0.027 CID_154699729 | CID_154699729 | |
| 0.097 | 0.058 | 0.097 | Prolactin inhibitor | |||
| 0.058 | 0.019 | 0.058 | Adenylate cyclase 1 inhibitor | |||
| 0.05 | 0.012 | 0.05 | Glutamate (mGluR8) agonist | |||
| 0.091 | 0.054 | 0.091 | Histamine N-methyltransferase inhibitor | |||
| 0.066 | 0.03 | 0.066 | Carbonic anhydrase VB inhibitor | |||
| 0.051 | 0.015 | 0.051 | Sphingosine 1-phosphate receptor 3 agonist | |||
| 0.085 | 0.049 | 0.129 | Glycine receptor antagonist | 0.129 0.014 CID_154699729 | CID_154699729 | |
| 0.082 | 0.047 | 0.082 | Keratolytic | |||
| 0.043 | 0.008 | 0.043 | CC chemokine 1 receptor antagonist | |||
| 0.099 | 0.065 | 0.099 | 5-Lipoxygenase inhibitor | |||
| 0.104 | 0.071 | 0.104 | CDC-like kinase 3 inhibitor | |||
| 0.062 | 0.029 | 0.062 | Alpha tubulin antagonist | |||
| 0.075 | 0.043 | 0.075 | Prostaglandin-E synthase inhibitor | |||
| 0.059 | 0.027 | 0.059 | Aconitate hydratase inhibitor | |||
| 0.039 | 0.007 | 0.161 | Sodium/glucose cotransporter inhibitor | 0.161 0.002 CID_154699729 | CID_154699729 | |
| 0.085 | 0.054 | 0.085 | Glutathione S-transferase inhibitor | |||
| 0.064 | 0.033 | 0.064 | Beta 2 adrenoreceptor agonist | |||
| 0.055 | 0.023 | 0.055 | Cholesterol esterase inhibitor | |||
| 0.07 | 0.039 | 0.07 | MDM2 inhibitor | |||
| 0.074 | 0.042 | 0.074 | Carbonic anhydrase VA inhibitor | |||
| 0.132 | 0.101 | 0.132 | MAP kinase 3 inhibitor | |||
| 0.062 | 0.031 | 0.062 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.068 | 0.037 | 0.068 | 5 Hydroxytryptamine 3 agonist | |||
| 0.068 | 0.038 | 0.068 | Beta 3 adrenoreceptor antagonist | |||
| 0.056 | 0.026 | 0.056 | CXC chemokine 1 receptor antagonist | |||
| 0.068 | 0.039 | 0.068 | Dopamine D3 antagonist | |||
| 0.086 | 0.058 | 0.086 | NMDA receptor antagonist | |||
| 0.065 | 0.036 | 0.065 | Biliverdin reductase inhibitor | |||
| 0.083 | 0.054 | 0.083 | Opioid kappa receptor antagonist | |||
| 0.052 | 0.025 | 0.052 | Carbonic anhydrase VII inhibitor | |||
| 0.064 | 0.038 | 0.064 | Alpha 2 adrenoreceptor agonist | |||
| 0.058 | 0.032 | 0.058 | Dihydroorotate oxidase inhibitor | |||
| 0.076 | 0.05 | 0.076 | Vanilloid 4 agonist | |||
| 0.065 | 0.04 | 0.065 | Transcription factor RelA inhibitor | |||
| 0.055 | 0.03 | 0.055 | 5 Hydroxytryptamine 4 antagonist | |||
| 0.146 | 0.12 | 0.182 | Psychostimulant | 0.182 0.091 CID_154699729 | CID_154699729 | |
| 0.034 | 0.009 | 0.034 | Thyroid hormone agonist | |||
| 0.16 | 0.135 | 0.337 | Cyclic AMP phosphodiesterase inhibitor | 0.337 0.029 CID_154699729 | CID_154699729 | |
| 0.046 | 0.021 | 0.046 | Heme oxygenase inhibitor | |||
| 0.041 | 0.016 | 0.043 | Ceramide glucosyltransferase inhibitor | 0.043 0.013 CID_154699729 | CID_154699729 | |
| 0.107 | 0.083 | 0.107 | Sphingosine 1-phosphate receptor 2 agonist | |||
| 0.038 | 0.014 | 0.038 | Protein kinase (CK2) beta inhibitor | |||
| 0.042 | 0.018 | 0.042 | Glutamate (mGluR3) antagonist | |||
| 0.065 | 0.042 | 0.065 | 5 Hydroxytryptamine 2A agonist | |||
| 0.067 | 0.043 | 0.067 | Beta adrenoreceptor antagonist | |||
| 0.042 | 0.02 | 0.042 | Leukotriene C4 antagonist | |||
| 0.033 | 0.011 | 0.033 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.243 | 0.221 | 0.845 | Cyclophilin D inhibitor | 0.845 0.005 CID_154699729 | CID_154699729 | |
| 0.049 | 0.027 | 0.049 | Dopamine D2 agonist | |||
| 0.063 | 0.041 | 0.063 | Adrenaline uptake inhibitor | |||
| 0.124 | 0.102 | 0.124 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | |||
| 0.065 | 0.043 | 0.065 | Carbonic anhydrase inhibitor | 0.057 0.049 CID_154699729 | ||
| 0.047 | 0.025 | 0.047 | Glutamate (mGluR group III) antagonist | |||
| 0.091 | 0.07 | 0.091 | Bile acid receptor antagonist | |||
| 0.04 | 0.019 | 0.04 | Fumarate hydratase inhibitor | 0.031 0.027 CID_154699729 | ||
| 0.06 | 0.039 | 0.06 | Ryanodine receptor antagonist | |||
| 0.041 | 0.02 | 0.041 | Vanilloid 3 antagonist | |||
| 0.126 | 0.106 | 0.126 | Phospholipase A2 inhibitor | |||
| 0.137 | 0.117 | 0.137 | Tumour necrosis factor antagonist | |||
| 0.105 | 0.085 | 0.105 | Acetylcholine muscarinic antagonist | |||
| 0.123 | 0.104 | 0.123 | Acetylcholine M1 receptor antagonist | |||
| 0.076 | 0.058 | 0.076 | MAP kinase kinase 7 inhibitor | |||
| 0.035 | 0.017 | 0.035 | Glutamate (mGluR3) agonist | |||
| 0.026 | 0.009 | 0.026 | Isoleucine-tRNA ligase inhibitor | 0.022 0.017 CID_154699729 | ||
| 0.043 | 0.026 | 0.043 | Thymidine kinase inhibitor | |||
| 0.053 | 0.036 | 0.182 | Heparanase inhibitor | 0.182 0.002 CID_154699729 | CID_154699729 | |
| 0.053 | 0.037 | 0.112 | Alpha-mannosidase inhibitor | 0.112 0.005 CID_154699729 | CID_154699729 | |
| 0.024 | 0.008 | 0.024 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.044 | 0.029 | 0.044 | Glutamate (mGluR4) antagonist | |||
| 0.04 | 0.025 | 0.04 | Urate transporter 1 inhibitor | |||
| 0.062 | 0.048 | 0.062 | Leukotriene antagonist | |||
| 0.069 | 0.055 | 0.069 | Phospholipase D inhibitor | |||
| 0.043 | 0.028 | 0.043 | Sphingosine 1-phosphate receptor 1 agonist | |||
| 0.06 | 0.046 | 0.06 | NMDA 2C receptor antagonist | |||
| 0.043 | 0.029 | 0.043 | Oxytocin agonist | |||
| 0.08 | 0.066 | 0.094 | T cell inhibitor | 0.094 0.032 CID_154699729 | CID_154699729 | |
| 0.045 | 0.031 | 0.045 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.028 | 0.015 | 0.028 | Thymidine kinase (Herpes simplex virus 1) inhibitor | |||
| 0.034 | 0.021 | 0.034 | Catechol O-methyltransferase inhibitor | |||
| 0.108 | 0.095 | 0.108 | Glycogen synthase kinase-3 alpha inhibitor | |||
| 0.027 | 0.014 | 0.027 | Dopamine autoreceptor agonist | |||
| 0.041 | 0.029 | 0.041 | Kainate receptor agonist | |||
| 0.03 | 0.018 | 0.03 | Purinergic P2Y15 antagonist | |||
| 0.019 | 0.007 | 0.019 | Thromboxane A2 agonist | |||
| 0.031 | 0.019 | 0.031 | Liver X receptor beta antagonist | |||
| 0.054 | 0.042 | 0.054 | Argininosuccinate synthase inhibitor | |||
| 0.028 | 0.016 | 0.028 | CXC chemokine 2 receptor antagonist | |||
| 0.095 | 0.084 | 0.124 | Protein-tyrosine phosphatase 1B inhibitor | 0.124 0.06 CID_154699729 | CID_154699729 | |
| 0.028 | 0.017 | 0.028 | Hedgehog signaling activator | |||
| 0.055 | 0.044 | 0.055 | Dopamine uptake inhibitor | |||
| 0.025 | 0.014 | 0.025 | Fructose-1,6-bisphosphatase 1 inhibitor | |||
| 0.042 | 0.031 | 0.042 | Glutamate (mGluR group III) agonist | |||
| 0.067 | 0.057 | 0.067 | Catalase inhibitor | |||
| 0.095 | 0.085 | 0.095 | Chelator | |||
| 0.052 | 0.042 | 0.052 | Carbonic anhydrase II inhibitor | |||
| 0.036 | 0.026 | 0.08 | Arginase inhibitor | 0.08 0.006 CID_154699729 | CID_154699729 | |
| 0.038 | 0.029 | 0.038 | Dopamine D3 agonist | |||
| 0.067 | 0.058 | 0.067 | Aminopeptidase I inhibitor | |||
| 0.087 | 0.078 | 0.087 | Alpha 2c adrenoreceptor antagonist | |||
| 0.198 | 0.19 | 0.198 | Calpain 2 inhibitor | |||
| 0.044 | 0.036 | 0.044 | Beta adrenoreceptor agonist | |||
| 0.025 | 0.017 | 0.041 | Vanilloid 2 agonist | 0.041 0.004 CID_154699729 | CID_154699729 | |
| 0.05 | 0.042 | 0.05 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.076 | 0.069 | 0.076 | Inducible nitric-oxide synthase inhibitor | |||
| 0.017 | 0.01 | 0.017 | Thyroid hormone alpha agonist | |||
| 0.046 | 0.039 | 0.046 | Topoisomerase II beta inhibitor | |||
| 0.077 | 0.07 | 0.077 | Ornithine decarboxylase inhibitor | |||
| 0.026 | 0.019 | 0.026 | Integrin alpha2beta1 antagonist | |||
| 0.075 | 0.068 | 0.075 | Calcium antagonist | |||
| 0.098 | 0.091 | 0.098 | c-Src kinase inhibitor | |||
| 0.219 | 0.213 | 0.219 | DNA directed DNA polymerase inhibitor | |||
| 0.098 | 0.092 | 0.144 | Photosensitizer | 0.144 0.035 CID_154699729 | CID_154699729 | |
| 0.019 | 0.013 | 0.019 | Endothelin B receptor antagonist | |||
| 0.121 | 0.116 | 0.121 | Thiol protease inhibitor | |||
| 0.026 | 0.021 | 0.026 | Endothelin receptor antagonist | |||
| 0.017 | 0.012 | 0.024 | Telomerase stimulant | 0.024 0.005 CID_154699729 | CID_154699729 | |
| 0.035 | 0.03 | 0.035 | Integrin alpha2 antagonist | |||
| 0.175 | 0.171 | 0.175 | Transcription factor STAT3 inhibitor | |||
| 0.013 | 0.009 | 0.013 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | |||
| 0.027 | 0.023 | 0.027 | Estrogen-related receptor gamma antagonist | |||
| 0.067 | 0.063 | 0.067 | CYP2A6 inhibitor | |||
| 0.023 | 0.02 | 0.023 | Glutamate (mGluR1) agonist | |||
| 0.04 | 0.037 | 0.04 | Sphingosine 1-phosphate receptor agonist | |||
| 0.038 | 0.035 | 0.038 | Carbonic anhydrase IV inhibitor | |||
| 0.006 | 0.004 | 0.006 | Insulin like growth factor 3 antagonist | |||
| 0.022 | 0.02 | 0.022 | NMDA receptor glycine site antagonist | |||
| 0.037 | 0.035 | 0.037 | Liver X receptor alpha agonist | |||
| 0.032 | 0.031 | 0.032 | Nicotinic acid receptor agonist | |||
| 0.063 | 0.062 | 0.063 | Telomerase inhibitor | |||
| 0.03 | 0.029 | 0.03 | Progesterone antagonist | |||
| 0.04 | 0.041 | 0.112 | Mannosidase inhibitor | 0.112 0.005 CID_154699729 | CID_154699729 | |
| 0.02 | 0.022 | 0.021 | Dopamine D1 agonist | 0.021 0.018 CID_154699729 | CID_154699729 | |
| 0.041 | 0.045 | 0.097 | Carbonic anhydrase XII inhibitor | 0.097 0.021 CID_154699729 | CID_154699729 | |
| 0.036 | 0.04 | 0.051 | Guanylate cyclase inhibitor | 0.051 0.02 CID_154699729 | CID_154699729 | |
| 0.05 | 0.058 | 0.073 | Adenine nucleotide translocase inhibitor | 0.073 0.013 CID_154699729 | CID_154699729 | |
| 0.04 | 0.049 | 0.08 | Carbonic anhydrase XIV inhibitor | 0.08 0.017 CID_154699729 | CID_154699729 | |
| 0.007 | 0.017 | 0.011 | Purinergic P2Y2 agonist | 0.011 0.006 CID_154699729 | CID_154699729 | |
| 0.015 | 0.027 | 0.026 | Antibiotic Anthracycline-like | 0.026 0.005 CID_154699729 | CID_154699729 | |
| 0.087 | 0.099 | 0.103 | Mucolytic | 0.103 0.074 CID_154699729 | CID_154699729 | |
| 0.038 | 0.053 | 0.064 | Carbonic anhydrase IX inhibitor | 0.064 0.035 CID_154699729 | CID_154699729 | |
| 0.031 | 0.051 | 0.118 | Phosphorylase inhibitor | 0.118 0.01 CID_154699729 | CID_154699729 | |
| 0.042 | 0.063 | 0.055 | Leukotriene B4 antagonist | 0.055 0.035 CID_154699729 | CID_154699729 | |
| 0.18 | 0.204 | 0.609 | Antithrombotic | 0.609 0.015 CID_154699729 | CID_154699729 | |
| 0.041 | 0.065 | 0.11 | Glucose-6-phosphate translocase inhibitor | 0.11 0.005 CID_154699729 | CID_154699729 | |
| 0.071 | 0.109 | 0.15 | Thioredoxin inhibitor | 0.15 0.017 CID_154699729 | CID_154699729 | |
| 0.072 | 0.11 | 0.261 | Expectorant | 0.261 0.011 CID_154699729 | CID_154699729 | |
| 0.079 | 0.12 | 0.184 | Alkylator | 0.184 0.031 CID_154699729 | CID_154699729 | |
| 0.049 | 0.094 | 0.063 | Interferon inducer | 0.063 0.046 CID_154699729 | CID_154699729 | |
| 0.044 | 0.091 | 0.233 | Antineoplastic antibiotic | 0.233 0.016 CID_154699729 | CID_154699729 | |
| 0.109 | 0.159 | 0.459 | Platelet adhesion inhibitor | 0.459 0.007 CID_154699729 | CID_154699729 | |
| 0.024 | 0.078 | 0.087 | Antibiotic Aminoglycoside-like | 0.087 0.004 CID_154699729 | CID_154699729 | |
| 0.055 | 0.11 | 0.079 | Interferon agonist | 0.079 0.054 CID_154699729 | CID_154699729 | |
| 0.074 | 0.136 | 0.109 | Phosphodiesterase 6D inhibitor | 0.109 0.037 CID_154699729 | CID_154699729 | |
| 0.012 | 0.077 | 0.067 | Protein 30S ribosomal subunit inhibitor | 0.067 0.005 CID_154699729 | CID_154699729 | |
| 0.065 | 0.135 | 0.176 | DNA intercalator | 0.176 0.033 CID_154699729 | CID_154699729 | |
| 0.033 | 0.105 | 0.046 | Cytokine production stimulant | 0.046 0.042 CID_154699729 | CID_154699729 | |
| 0.099 | 0.172 | 0.373 | Hemostatic | 0.373 0.009 CID_154699729 | CID_154699729 | |
| 0.164 | 0.242 | 0.496 | Apoptosis antagonist | 0.496 0.021 CID_154699729 | CID_154699729 | |
| 0.118 | 0.196 | 0.282 | Interleukin agonist | 0.282 0.058 CID_154699729 | CID_154699729 | |
| 0.104 | 0.189 | 0.213 | Interleukin 6 antagonist | 0.213 0.034 CID_154699729 | CID_154699729 | |
| 0.064 | 0.15 | 0.177 | DNA polymerase I inhibitor | 0.177 0.036 CID_154699729 | CID_154699729 | |
| 0.06 | 0.149 | 0.163 | Transcription factor NF kappa B stimulant | 0.163 0.013 CID_154699729 | CID_154699729 | |
| 0.042 | 0.142 | 0.069 | Lipocortins synthesis agonist | 0.069 0.022 CID_154699729 | CID_154699729 | |
| 0.157 | 0.264 | 0.345 | Antiobesity | 0.345 0.09 CID_154699729 | CID_154699729 | |
| 0.049 | 0.159 | 0.138 | Mediator release inhibitor | 0.138 0.034 CID_154699729 | CID_154699729 | |
| 0.023 | 0.135 | 0.097 | Neuraminidase inhibitor | 0.097 0.016 CID_154699729 | CID_154699729 | |
| 0.03 | 0.157 | 0.105 | Neuraminidase (influenza) inhibitor | 0.105 0.015 CID_154699729 | CID_154699729 | |
| 0.02 | 0.147 | 0.06 | Neuraminidase (Influenza A) inhibitor | 0.06 0.013 CID_154699729 | CID_154699729 | |
| 0.006 | 0.138 | 0.041 | Squalene synthetase inhibitor | 0.041 0.018 CID_154699729 | CID_154699729 | |
| 0.015 | 0.155 | 0.059 | Prostaglandin EP2 antagonist | 0.059 0.042 CID_154699729 | CID_154699729 | |
| 0.065 | 0.21 | 0.09 | Folate antagonist | 0.09 0.087 CID_154699729 | CID_154699729 | |
| 0.085 | 0.243 | 0.335 | Hypolipemic | 0.335 0.039 CID_154699729 | CID_154699729 | |
| 0.076 | 0.264 | 0.31 | Insulin secretagoues | 0.31 0.011 CID_154699729 | CID_154699729 | |
| 0.042 | 0.237 | 0.09 | Falcipain 2 inhibitor | 0.09 0.059 CID_154699729 | CID_154699729 | |
| 0.042 | 0.244 | 0.092 | Falcipain inhibitor | 0.092 0.061 CID_154699729 | CID_154699729 | |
| 0.117 | 0.32 | 0.414 | Peptidyltransferase inhibitor | 0.414 0.006 CID_154699729 | CID_154699729 | |
| 0.027 | 0.244 | 0.053 | Factor III inhibitor | 0.053 0.028 CID_154699729 | CID_154699729 | |
| 0.027 | 0.257 | 0.1 | Histone deacetylase SIRT1 stimulant | 0.1 0.028 CID_154699729 | CID_154699729 | |
| 0.027 | 0.257 | 0.1 | Histone deacetylase stimulant | 0.1 0.028 CID_154699729 | CID_154699729 | |
| 0.051 | 0.281 | 0.773 | Angiogenesis stimulant | 0.773 0.004 CID_154699729 | CID_154699729 | |
| 0.001 | 0.266 | 0.014 | Antibiotic Macrolide-like | 0.014 0.01 CID_154699729 | CID_154699729 | |
| 0.114 | 0.414 | 0.43 | Interleukin 2 agonist | 0.43 0.02 CID_154699729 | CID_154699729 | |
| 0.011 | 0.312 | 0.047 | Microtubule stabilization | 0.047 0.032 CID_154699729 | CID_154699729 | |
| 0.01 | 0.337 | 0.386 | Selectin antagonist | 0.386 0.003 CID_154699729 | CID_154699729 | |
| 0.013 | 0.351 | 0.118 | Protein 50S ribosomal subunit inhibitor | 0.118 0.01 CID_154699729 | CID_154699729 | |
| 0.119 | 0.48 | 0.78 | Antiinflammatory | 0.78 0.018 CID_154699729 | CID_154699729 | |
| 0.043 | 0.426 | 0.103 | Interleukin 12 antagonist | 0.103 0.049 CID_154699729 | CID_154699729 | |
| 0.014 | 0.405 | 0.063 | Nitric oxide donor | 0.063 0.043 CID_154699729 | CID_154699729 | |
| 0.004 | 0.414 | 0.028 | 1,3-Beta-glucan synthase inhibitor | 0.028 0.022 CID_154699729 | CID_154699729 | |
| 0.023 | 0.447 | 0.321 | Thrombolytic | 0.321 0.021 CID_154699729 | CID_154699729 | |
| 0.016 | 0.493 | 0.088 | Factor IXa inhibitor | 0.088 0.013 CID_154699729 | CID_154699729 | |
| 0.016 | 0.498 | 0.14 | Cell adhesion molecule inhibitor | 0.14 0.018 CID_154699729 | CID_154699729 | |
| 0.009 | 0.494 | 0.062 | DNA gyrase inhibitor | 0.062 0.045 CID_154699729 | CID_154699729 | |
| 0.026 | 0.525 | 0.277 | Cell adhesion inhibitor | 0.277 0.012 CID_154699729 | CID_154699729 | |
| 0.051 | 0.572 | 0.513 | Immunomodulator | 0.513 0.021 CID_154699729 | CID_154699729 | |
| 0.03 | 0.56 | 0.37 | Tumour necrosis factor alpha release inhibitor | 0.37 0.033 CID_154699729 | CID_154699729 | |
| 0.009 | 0.617 | 0.034 | Toll-Like receptor 4 agonist | 0.034 0.008 CID_154699729 | CID_154699729 | |
| 0.015 | 0.638 | 0.314 | Platelet antagonist | 0.314 0.048 CID_154699729 | CID_154699729 | |
| 0.005 | 0.841 | 0.212 | Anticoagulant | 0.212 0.049 CID_154699729 | CID_154699729 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |